Healthcare Giants NVO & LLY Eye Trillion-Dollar Club

2024-02-01

The Government Pension Fund Global predicts that $Novo-Nordisk A/S(NVO)$ and $Eli Lilly(LLY)$ could be the first healthcare companies to reach trillion-dollar club, benefiting from the rising demand for diabetes and weight-loss drugs.

With less than 1% of overweight individuals currently receiving treatment, the potential market for these drugs remains vast.

$Novo-Nordisk A/S(NVO)$'s strong earnings, driven by the success of its drug Wegovy, pushed its market value to $511.29 bln.

While $Eli Lilly(LLY)$’s market capitalization stands at around $612 bln.

The Government Pension Fund Global holds significant stakes in both companies and sees promising opportunities for their drugs beyond weight loss, potentially addressing conditions like chronic kidney disease and Alzheimer's.

If these forecasts hold true, Novo Nordisk and Eli Lilly could join the ranks of trillion-dollar healthcare giants, akin to tech companies like Microsoft and Apple.

LLY Beats vs. NVO Misses:Which Weight Loss Drug Do You Favor?

Eli Lilly expects fiscal year revenue to be between $45.4 billion and $46.6 billion, up from the previous forecast of $42.4 billion to $43.6 billion. Eli Lilly's stock surged 10% in pre-market trading. Novo Nordisk (NVO) stock tumbled Wednesday after the Danish drugmaker reported a rare sales miss. ------------ Which weight loss drug company is a better buy?

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

tothehill
2024-02-01
tothehill
Hilarious market potential! 😂 Agree! 🙌
KSR
2024-02-02
KSR
👍

Leave a comment

472

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":269377699418120,"tweetId":"269377699418120","gmtCreate":1706790651828,"gmtModify":1707122633500,"author":{"id":3527667668165440,"idStr":"3527667668165440","authorId":3527667668165440,"authorIdStr":"3527667668165440","name":"Capital_Insights","avatar":"https://static.tigerbbs.com/cfdc66fff48bb2b9e2d328ac5eb33100","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3022,"starInvestorFlag":false},"themes":[{"themeId":"3ba18faeb8364f42b810a81bee429b4d","categoryId":"7a15628ce2174325bddc6229505e0d70","name":"LLY Beats vs. NVO Misses:Which Weight Loss Drug Do You Favor?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":3ba18faeb8364f42b810a81bee429b4d}&rnconfig={\"headerBarHidden\": true}","description":"Eli Lilly expects fiscal year revenue to be between $45.4 billion and $46.6 billion, up from the previous forecast of $42.4 billion to $43.6 billion. Eli Lilly's stock surged 10% in pre-market trading.\nNovo Nordisk (NVO) stock tumbled Wednesday after the Danish drugmaker reported a rare sales miss.\n------------\nWhich weight loss drug company is a better buy?","image":"https://community-static.tradeup.com/news/96ede51e656d3728375f75b1fee3f8e4"}],"images":[{"img":"https://community-static.tradeup.com/news/5d7a758ba9b42553dfa4c4a186caf25e","width":"1540","height":"705"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/5d7a758ba9b42553dfa4c4a186caf25e","width":"1540","height":"705"}],"title":"Healthcare Giants NVO & LLY Eye Trillion-Dollar Club","html":"<html><head></head><body>The Government Pension Fund Global predicts that <a data-mention-id=\"NVO\" class=\"teditor-mention\" data-mention-name=\"Novo-Nordisk A/S\" href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a> and <a data-mention-id=\"LLY\" class=\"teditor-mention\" data-mention-name=\"Eli Lilly\" href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> could be the first healthcare companies to reach trillion-dollar club, benefiting from the rising demand for diabetes and weight-loss drugs. <img src=\"https://community-static.tradeup.com/news/5d7a758ba9b42553dfa4c4a186caf25e\" tg-width=\"1540\" tg-height=\"705\">With less than 1% of overweight individuals currently receiving treatment, the potential market for these drugs remains vast. <blockquote> <a data-mention-id=\"NVO\" class=\"teditor-mention\" data-mention-name=\"Novo-Nordisk A/S\" href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a>'s strong earnings, driven by the success of its drug Wegovy, pushed its market value to $511.29 bln.</blockquote><blockquote>While <a data-mention-id=\"LLY\" class=\"teditor-mention\" data-mention-name=\"Eli Lilly\" href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a>’s market capitalization stands at around $612 bln. </blockquote>The Government Pension Fund Global holds significant stakes in both companies and sees promising opportunities for their drugs beyond weight loss, potentially addressing conditions like chronic kidney disease and Alzheimer's. If these forecasts hold true, Novo Nordisk and Eli Lilly could join the ranks of trillion-dollar healthcare giants, akin to tech companies like Microsoft and Apple. </body></html>","htmlText":"<html><head></head><body>The Government Pension Fund Global predicts that <a data-mention-id=\"NVO\" class=\"teditor-mention\" data-mention-name=\"Novo-Nordisk A/S\" href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a> and <a data-mention-id=\"LLY\" class=\"teditor-mention\" data-mention-name=\"Eli Lilly\" href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> could be the first healthcare companies to reach trillion-dollar club, benefiting from the rising demand for diabetes and weight-loss drugs. <img src=\"https://community-static.tradeup.com/news/5d7a758ba9b42553dfa4c4a186caf25e\" tg-width=\"1540\" tg-height=\"705\">With less than 1% of overweight individuals currently receiving treatment, the potential market for these drugs remains vast. <blockquote> <a data-mention-id=\"NVO\" class=\"teditor-mention\" data-mention-name=\"Novo-Nordisk A/S\" href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a>'s strong earnings, driven by the success of its drug Wegovy, pushed its market value to $511.29 bln.</blockquote><blockquote>While <a data-mention-id=\"LLY\" class=\"teditor-mention\" data-mention-name=\"Eli Lilly\" href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a>’s market capitalization stands at around $612 bln. </blockquote>The Government Pension Fund Global holds significant stakes in both companies and sees promising opportunities for their drugs beyond weight loss, potentially addressing conditions like chronic kidney disease and Alzheimer's. If these forecasts hold true, Novo Nordisk and Eli Lilly could join the ranks of trillion-dollar healthcare giants, akin to tech companies like Microsoft and Apple. </body></html>","text":"The Government Pension Fund Global predicts that $Novo-Nordisk A/S(NVO)$ and $Eli Lilly(LLY)$ could be the first healthcare companies to reach trillion-dollar club, benefiting from the rising demand for diabetes and weight-loss drugs. With less than 1% of overweight individuals currently receiving treatment, the potential market for these drugs remains vast. $Novo-Nordisk A/S(NVO)$'s strong earnings, driven by the success of its drug Wegovy, pushed its market value to $511.29 bln. While $Eli Lilly(LLY)$’s market capitalization stands at around $612 bln. The Government Pension Fund Global holds significant stakes in both companies and sees promising opportunities for their drugs beyond weight loss, potentially addressing conditions like chronic kidney disease and Alzheimer's. If these forecasts hold true, Novo Nordisk and Eli Lilly could join the ranks of trillion-dollar healthcare giants, akin to tech companies like Microsoft and Apple.","highlighted":1,"essential":2,"paper":2,"likeSize":472,"commentSize":2,"repostSize":72,"favoriteSize":0,"link":"https://ttm.financial/post/269377699418120","repostId":0,"isVote":1,"tweetType":1,"viewCount":3508,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["LLY","NVO"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":true,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":816,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":269410834292816,"commentId":"269410834292816","gmtCreate":1706790970325,"gmtModify":1706855090828,"authorId":3479274781763777,"author":{"id":3479274781763777,"idStr":"3479274781763777","authorId":3479274781763777,"name":"tothehill","avatar":"https://static.tigerbbs.com/d63237e21ae39bc54951c8ab6ec41ee9","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":269377699418120,"objectIdStr":"269377699418120","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Hilarious market potential! 😂 Agree! 🙌","text":"Hilarious market potential! 😂 Agree! 🙌","html":"Hilarious market potential! 😂 Agree! 🙌","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":269602863333560,"commentId":"269602863333560","gmtCreate":1706837998989,"gmtModify":1706838011388,"authorId":4121076730674632,"author":{"id":4121076730674632,"idStr":"4121076730674632","authorId":4121076730674632,"name":"KSR","avatar":"https://community-static.tradeup.com/news/7326507c34f41020b4293ec0bc34a77a","vip":1,"crmLevel":11,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":269377699418120,"objectIdStr":"269377699418120","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"👍","text":"👍","html":"👍","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/269377699418120"}